This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...